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Background: Inadequate diagnosis and suboptimal control of hypertension is a major driver of cardiovascular
morbidity and mortality in Africa. Understanding the levels of awareness, treatment and control of hypertension
and the associated factors has important implications for hypertension control efforts.
Methods: The PubMed database was searched for original articles related to awareness, treatment and control of
hypertension in Africa published between 1993 and 2013. The key search terms were: Africa, awareness, treatment,
control, and hypertension. Exploration of bibliographies cited in the identified articles was done to provide further
studies. Full texts of the articles were obtained from various internet sources and individual authors. A data
extraction sheet was used to collect this information.
Results: Thirty eight studies drawn from 23 African countries from all regions of the continent met the inclusion
criteria. The levels of awareness, treatment and control varied widely from country to country. Rural populations had
lower levels of awareness than urban areas. North African countries had the highest levels of treatment in the
continent. There was generally poor control of hypertension across the region even among subjects that were aware
of their status and those that were treated. On the whole, the women had a better control status than the men.
Conclusion: There are low levels of awareness and treatment of hypertension and even lower levels of control. Tailored
research is required to uncover specific reasons behind these low levels of awareness and treatment, and especially
control, in order to inform policy formulation for the improvement of outcomes of hypertensive patients in Africa.
Keywords: Hypertension, Awareness, Control, Gender, Associated factorsBackground
Cardiovascular disease (CVD) is the leading cause of
death in developing countries where it causes nearly as
many deaths as HIV, malaria and tuberculosis [1,2].
Africa, a continent of 53 countries and one billion
people is not only beleaguered by a huge burden of in-
fectious disease but also bears a considerable proportion
of the world’s CVD burden [3]. Presently, the age-
specific mortality rates from CVDs are much higher in
younger age groups in both men and women in Africa
than in the developed world [4]. CVD is the second
leading overall cause of death in Africa, after HIV/AIDS,
and is the leading cause of mortality among individuals
over the age of thirty [5]. The World Health Organisa-
tion (WHO) projects that over the next ten years Africa* Correspondence: jkkayima@gmail.com
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reproduction in any medium, provided the orwill experience the largest increase in death rates from
CVD and therefore the negative economic impact of
CVD will be more felt on the continent [3].
Hypertension is the driver of the CVD epidemic in
Africa where it is a major, independent risk factor for
heart failure, and stroke and kidney failure [6]. The man-
agement of these complications is difficult to sustain in
sub-Saharan countries where resource-intensive care is
not very feasible. Insufficient diagnosis of hypertension
and suboptimal blood pressure control in the diagnosed
patients increases morbidity and mortality with an in-
creased burden to health care resources [7]. In devel-
oped countries, the improved control of hypertension
has led to considerable reduction in overall morbidity
and mortality over the last fifty years [8,9]. Evidence
from large clinical trials has shown a 40% reduction in
stroke and a reduction of at least 25% in myocardialLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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hypertension [10,11].
The increasing awareness of hypertension as an import-
ant cause of morbidity and mortality in Africa over the last
twenty years has resulted in numerous publications
documenting the burden of hypertension in Africa which
now calls for systematic reviews to provide a comprehen-
sive understanding of the situation in order to inform the
design of tailored control and research efforts. In 2007,
Addo et al. published a systematic review which showed
extensively varying prevalence of hypertension with higher
prevalence rates in the urban than rural areas in Sub-
Saharan. There was marginal reporting on the levels of
awareness, treatment or control in that publication [12].
Since then, there have been several studies conducted that
have further highlighted the challenge of awareness, treat-
ment and control of hypertension. This systematic review
is therefore intended to evaluate the available data on
levels of awareness, treatment and control of hypertension
in Africa with a view of suggesting measures that could
improve control among hypertensive patients.
Methods
This systematic review followed the guidelines set out by
Preferred Reporting Items for Systematic reviews and
Meta-Analyses (PRISMA) statement [13]. We consid-
ered articles published in all languages between 1993
and 2013 to give a more comprehensive and current ap-
praisal of awareness, treatment and control of hyperten-
sion in Africa. Journal articles in other languages were
translated to English. To ensure relative homogeneity
and comparability of the studies, we considered only
community based cross-sectional studies that reported
awareness, treatment and control of hypertension. We
considered articles that defined hypertension as a mea-
sured blood pressure of >140 systolic and >90 diastolic;
awareness as the prior knowledge of hypertensive status;
treatment as any attempted pharmacological therapy for
hypertension in patients who were aware of their status
and control as a blood pressure of <140 systolic and
<90 mmHg diastolic in treated hypertensive subjects.
We included studies that used both automated and mer-
cury sphygmomanometers as blood pressure measuring
devices, and surveys that had a sample size of at least
350 participants. Non-pharmacological therapy is an im-
portant way of controlling hypertension and indeed a
first line for pre-hypertension. However, the studies in-
cluded, described only control with pharmacological
therapy because this is a more demonstrable way of
therapy. We excluded studies in which hypertension sta-
tus was determined using one blood pressure reading.
We searched in PubMed using the key search terms:
Africa, awareness, treatment, control, and hypertension.
We also used individual country names for the 53African countries and hypertension as additional key
search terms to obtain articles on the subject. Eligible arti-
cles were assessed by one member of the team (JK). We
excluded all studies that were hospital based and all data
whose definitions of awareness, treatment and control dif-
fered from the agreed-on definitions. The abstracts of all
potentially relevant papers were reviewed and full articles
were accessed through Pub Med or Google Scholar or
HINARI. The references of all the relevant research arti-
cles were scrutinised for additional potential data sources.
The full texts of these studies were also accessed in a simi-
lar way. The authors whose full texts papers could not be
accessed by the numerous internet based sources used
were requested to provide them.
A data extraction sheet was used to collect informa-
tion about the country, the year of publication, the num-
ber of participants, the prevalence of hypertension and
the levels of awareness, treatment or control. Where the
factors that predicted the levels of awareness, treatment
and control were provided, these too were extracted.
Where possible, results from multinational studies were
disaggregated to show the status of awareness, treatment
and control within individual countries. Where it was
not possible to disaggregate the data by country, the
study was presented as one and the countries in which
the study was done were shown. In the publications con-
sidered, level of awareness was measured as a proportion
of the total numbers of hypertensive subjects that were
aware of their hypertensive status; level of treatment as a
proportion of the subjects who were aware of their
hypertensive status who were on pharmacological ther-
apy and level of control as the proportion of treated pa-
tients who attained a blood pressure of 140/90 mmHg.
The threshold statistical significance for factors that pre-
dicted hypertension was a p-value < 0.05. We also recorded
odds ratios in those publications that reported them.
Owing to the heterogeneity of the study designs and the
lack of reported confidence intervals in most the studies, a
combined analysis of the reported data could not be done.Results
Figure 1 shows the schema of the process of choosing
the studies that were included in the review. The pri-
mary PubMed search identified 40 articles. The country-
specific searches led to the identification of an additional
52 studies. We excluded six studies that considered ma-
ternal hypertension; eight that described awareness as
“knowledge of the effects of hypertension” rather than
“awareness of hypertensive status”; 19 review papers and
guidelines and 6 studies among Africans in the diaspora
(living outside the continent). Fifteen additional studies
were extracted from the bibliographies of the eligible ar-
ticles and included for review. Eventually 44 studies were
Other CVD risk factors= 19
Primary search= 40
Country specific search=52
Studies from references =15
Total initially identified
studies= 92
Review articles/ Guidelines= 19
Hospital based studies=4
Pregnancy related HTN =6
Included studies= 44
Diaspora studies= 7
Knowledge & practice studies= 8
Figure 1 Flow chart of literature search.
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control of hypertension in Africa.
Figure 2 shows the countries on the African continent
represented in the review. Overall, 26 of the 53 African
countries were represented from all the regions of the
continent. East Africa was represented by fourteen stud-
ies from seven countries [14-27]. Central Africa [28-33]
and North Africa [34-39] were each represented by six
studies. West Africa was represented by eleven studies
[21,40-49]. An additional four studies from South Africa
and Namibia were included in the survey [21,50-52].
Table 1 summarises the findings of the systematic re-
view including any factors associated with diagnosis,
treatment and control where available. The populations
represented in this review were diverse and included
both rural and urban subjects. Two of the articles were
from multinational studies [21,35]. An additional six
studies were nation-wide survey [29,30,36,37,53,54]. The
special communities represented in the studies were
slum dwellers in Kenya, gold miners in South Africa and
the market community in Nigeria [19,44,50].
The total number of participants in the review was
121, 220. The sample size ranged from 375 subjects in amarket place in Nigeria [44] to 27296 in a multinational
study in North Africa [35]. The age of the participants
ranged from 15 years to 99 years. Five studies focused
on the middle aged and elderly populations above forty
years [25,32,34,38,39]. All the studies had both genders
(male and female) represented. In most of the studies,
the women participants were more than the men. In
studies that targeted special communities- gold miners,
slum dwellers and market communities- the men had
more representation.Prevalence of hypertension
There was a wide variation in prevalence of hyperten-
sion. Most of the prevalence rates were not age-
standardised which made comparisons difficult. Among
the studies that considered younger populations under
35 years, the prevalence ranged from 9.3% in an
Ethiopian population to 48.1% in a Mozambican popu-
lation [16,22]. As expected, those studies that involved
the elderly populations had higher prevalence of hyper-
tension reaching 70% in an urban Tanzanian population
aged more than 70 years [25].
Figure 2 Map of Africa distribution of studies reviewed.
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Awareness in this review was described as prior know-
ledge of hypertensive status. The lowest levels of aware-
ness were found in rural communities in Nigeria (8%),
Uganda (10%) and Gabon (9%)[21,27,32]. The lowest
prevalence of awareness in urban areas was 12.3% among
slum dwellers in Nairobi. The highest awareness rates
were found in the studies that considered elderly subjects
reaching 81% in urban elderly populations of Tunisia [39].
Generally, studies from North African countries showed
the highest levels of awareness. The large multinational
Epidemiological Trial of Hypertension in North Africa
(ETHNA) that included 27296 subjects revealed awareness
rate of 71% among hypertensive patients [35]. West and
central Africa seemed to have the lowest levels of aware-
ness of hypertension status.Treatment
The treatment of hypertension ranged from 5% in a rural
Nigerian community to 91.2% in urban North African
populations [21,35]. East African populations had the low-
est levels of treatment while North African countries had
the highest levels. In studies done in Tanzania, for ex-
ample, the treatment rates ranged between 6.1% and 11%
whereas those done in North Africa varied between 24%
in an Egyptian national wide survey and 91.2% in the
ETHNA study [24,25,35,36]. There was no clear differencein treatment rates between urban and rural populations
across the regions.Control rates
Despite varying rates of awareness and treatment, the con-
trol rates were uniformly low and never exceeded 45%. Tan-
zanian populations- both urban and rural- had the lowest
levels ranging from as low as <1% and never exceeding 6.5%
in all the four studies that spanned twelve years. As with
awareness and treatment rates, the North African studies
showed the highest rate of control. The least levels of con-
trol in North Africa were recorded in Egypt at 8% with the
highest recorded in Morocco, Tunisia and Algeria in the
multinational ETHNA study [35,36].Factors affecting treatment awareness and control
Only 24 out of the 44 studies attempted to review any fac-
tors associated with awareness, treatment and control status.
In all the studies, the older age group had better awareness
and treatment rates. However, this did not universally trans-
late into better control of the blood pressure. In fact, two
studies reported better control in the young hypertensive pa-
tients [35,41]. Additionally, most studies revealed better
prevalence of awareness, treatment and control among the
women. Even the two studies that showed better awareness
of hypertensive status in men eventually revealed superior
treatment and control status in the women [25,47].





Factors associated with treatment,
awareness and control







Solet JL , 2008 [14] Islands 30–69 1268 44.0 33.0 27.0 Elderly more aware than the young
Eritrea
Mufunda, 2006 [15] Rural and
Urban
15–64 1160 1182 2342 15.6 20.0
Ethiopia
Muluneh AT, 2012 [16] Rural and
urban
15–64 2084 2385 4469 9.3 27.0
Awoke A , 2012 [17] Urban >35 679 28.3 63.0 42.2 Obesity and low physical activity associated with
poor control
Tesfaye F, 2009 [18] Urban 25–64 1398 1875 3713 31.5 35.2 11 28.0
Kenya
van de Vijver SJ, 2013 [19] Urban slums >18 2794 2396 5190 12.3 19.5 47 21.0
Jenson A, 2011 [20] Coastal area 162 307 469 43.1 46.5 31.2 7.3 Women more aware OR 4.58 (1.81–11.64); better treated
OR 4.02(1.89–8.54) and controlled OR 8.1(1.81–11.64) Older
>60 more aware OR6.01(1.11–32.48), better treated
OR3.22(1.00–10.32) and controlled 3.22(1.04–9.99)
Hendriks EM, 2011 [21] Rural >18 847 1264 2111 21.4 17.0 9 8.0
Mozambique
Damasceno et al., 2009 [22] Rural and
urban
25–64 1281 1800 3081 33.1 14.8 48.1 39.9 Women more aware (p < 0.007), better treated
(P < 0.021) and better controlled (p < 0.001)
Seychelles
Bovet et al., 2004 [23] Nationalwide
survey
1255 568 1823 39.2 65.0 62 24.1 Women more aware, treated and controlled
Tanzania
Dewhurst et al., 2012 [25] Elderly >70 972 1251 2223 70.0 37.7 6.1 0.9 Men better treated, women more controlled
Hendriks EM, 2011 [21] Urban >18 423 623 1046 23.7 18.0 9 5.0
Bovet P.,2002 [24] 9254 3659 5645 29.1 31.0 11 6.5 Women, better educated well controlled
Edwards R et al., 2000 [26] Rural and
urban
>15 402 526 928 30.0 20.0 10 <1.0 No difference in rural and urban
Uganda




















Table 1 Results of systematic review of hypertension awareness, treatment, control, and any associated factors from 44 studies in Africa, 1993-2013
(Continued)
Angola
Pires JE, 2013[28] Mainly urban 18-64 853 611 1,464 23.0 21.6 13.9 33.0 Awareness, higher in women (p < 0.001); older subjects
(p < 0.0001); non-smokers (p < 0.009). Lower in heavy
alcohol drinkers (p < 0.007)
Cameroon
Kamadjeu RM et al., 2006 [29] Nationwide
survey
>15 4007 6004 10,011 24.1 23.0 40.0 Older age, longer duration of HTN predicted awareness
and treatment
Dzudie A et al., 2012 [30] Nationwide
screen
>15 2120 1117 1,003 47.5 37.1 59.9 24.6
DRC. (Kinshasa)
Katchunga PB, 2011 [31] Rural and
urban
>20 699 40.2 42.5 30.5 13.6
Gabon
Ngoungou EB, 2012 [32] >40 313 423 736 51.9 9.9 19.4 5.8
Zimbambwe
Matenga, 1996 [33] > 34 749 33.3 26.1 22.4 47.8
Algeria
Temmar M, 2007 [34] Urban > rural 40–99 637 711 1348 44.0 30.0 25.0 Women controlled better than men (p < 0.001)
Nejjari C et al., 2013 [35] Multinational >18 27296 17339 10292 45.4 7.0 91.2 37.5 Control better in urban areas (p < 0.00001), younger
(p < 0.01), female(p < 0.01); university level (p < 0.00001);
non-smokers (p < 0.0001); those with normal BMI
(p < 0.00001); normal cholesterol level (p < 0.01)
Egypt
Ibrahim MM, 1995 [36] Nationwide
survey
25–95 2928 3804 6733 36.3 37.5 23.9 8.0 Better awareness, treatment and control in urban vs. rural.
Better awareness and treatment in those with severe HTN.
Better awareness and control in women and elderly
Tunisia
Romdhane BH, 2012 [37] Nationwide
survey
35–70 8007 30.6 38.8 84.4 24.1 Awareness better in older age group, females, lower
education, urban subjects
Hammami, 2011 [38] Urban elderly >65 202 396 598 52.0 81.0 78.0 30.7 Awareness better in elderly population, those with free
medications & the insured
Romdhane BH, 2005 [38] 40–60 1837 44.0 41.0 74.0 18.0
South Africa
Maepe LM, 2012 [50] Gold miners 18–69 3867 430 4297 39.5 42.0 31.0
Malhotra R, 2008 [51] 107 530 637 40.0 49.2 Younger age associated with better awareness; 35–54 yrs





















Table 1 Results of systematic review of hypertension awareness, treatment, control, and any associated factors from 44 studies in Africa, 1993-2013
(Continued)
Steyn K, 2008 [52] Nationwide 5738 8064 13801 21.0 M-41 F-67 M-39 f-58 M-26 F 38 Better control predicted by SES: richest vs poorest OR 2.33
(1.17–4.62) ; Race asian vs black OR 1.76(1.03–3.02); Age:
oldest age group vs youngest OR 26.23 (4.92–141); Insurance:
non-insured vs insured OR 0.59 (0.38–0.91)
Namibia
Hendriks EM, 2011 [21] Urban >18 771 962 1733 38.0 38.0 17 12
Benin
Houinato DS, 2012 [40] 3461 3392 6853 27.9 22.5 4.8 1.9
Ghana
Agyemang, 2006 [41] Rural urban >16 787 644 1431 29.4 34.0 28 6.2 Awareness better in older age (≥50-yr olds cf 16-34-yr olds
[OR = 6.14, (2.98–12.64). Treatment better in older age
≥50-year-olds OR: 6.25 ( 2.87–13.62); overweight OR
1.85(1.02, 3.34); traders OR 2.51(1.03–7.40]) Control better
in traders OR 2.51 (1.03–7.40) but poor in old age:
≥50-year-olds OR 0.11( 0.01–0.60)
Addo, 2006 [42] Rural >18 107 255 362 22.4 33.2 16.7
Amoah, 2003 [63] Urban >25 1893 2840 4733 28.3 34.0 18 4.0
Nigeria
Ulasi II, 2011 [44] Market
community
379 352 731 54.2 49.8
Oladapo OO, 2010 [45] 873 1127 2000 39.2 14.2 18.6 Transport, lack of drugs at health units,
competing priorities
Hendriks EM, 2011 [21] Rural,
multinational
>18 1247 1431 2678 19.3 8.0 5.0 3.0
Omuemu, 2007 [46] Rural 590 20.2 18.5 77.3 29.2 Women more aware, educated, elderly
Ekwunife, 2010 [47] >18 364 392 756 21.1 30.0 21.0 9.0 Men more aware, women more controlled
Senegal
Macia E, 2012 [48] Urban >50 263 237 500 64.5 49.5 70.6 17.4 Better awareness for women OR 2.4(1.41–4.07); elderly > 70 yrs
OR 2.15(1.11–4.17) but worse for the educated > 8 years OR
2.15 (1.01–4.6 ); those who had not visited HCW within the
year OR 0.37 ( 0.23–0.6) Better treatment and control for
those who had visited HCW within the last year (P < 0.001)
Togo
Yayehd K, 2011 [49] 2002 1095 905 36.7 42.4
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urban dwellings showed generally better hypertension
treatment and control status in the urban areas.
Additionally, subjects with better formal education and
literacy levels seemed to have better control. While
socio-economic status was not a frequently recorded
variable in the studies, the patients who had health in-
surance or who had access to private care had better
control [52]. Moreover North African countries, most of
which have access to universal health insurance had bet-
ter detection and treatment profiles, although these did
not translate into better control rate [39].
Discussion
There has been a wealth of information on the preva-
lence of hypertension on the African continent. A 2007
systematic review by Addo et al. had illustrated the high
prevalence of hypertension in numerous African states
[12]. Although our search terms did not include preva-
lence, this systematic review reveals varied levels of
prevalence across countries, a great many of which con-
firm persisting high rate. In a high prevalence setting
like Africa, it is of utmost importance to describe not
only the detection rate but also awareness, treatment
and control as well as the factors that influence these
rates. This would enable the formulation of relevant
tailor-made control strategies in order to reduce the
complications of uncontrolled hypertension. This sys-
tematic review is, to our knowledge, the most compre-
hensive analysis on awareness, treatment and control on
the African continent to date.
Our results show generally low levels of awareness of
hypertensive status with North African countries having
relatively better levels. The levels in Africa are much
lower than those in North America and Europe where
temporal reviews have shown an improvement in aware-
ness from twenty years ago when the levels where simi-
lar to the level currently seen in Africa to the present
rate of over 65% [53]. Most of this improved awareness
has been attributed to rigorous education programs on
hypertension after the realization that hypertension was
a major player in morbidity and mortality in these coun-
tries. Whereas the heterogeneous nature of the designs
of the study reviewed here could not allow the establish-
ment of a temporal trend in this review, no improve-
ment was realised in countries that had multiple
consecutive studies such as Tanzania. It is possible that
similar appreciation of hypertension as leading cause of
death would lead to improved education and therefore
improved awareness.
The treatment rates found by our review in North
Africa were much higher than those found elsewhere on
the continent. It is possible that the availability of health
insurance in countries such as Tunisia which coversboth diagnosis and treatment steers these high levels of
treatment. In Massachusetts USA, universal health in-
surance coverage has led to improved diagnosis and
control of hypertension leading to a reduction in hyper-
tension related hospitalisations and deaths [54]. It is pos-
sible that hypertension status will improve in countries
aiming to attain universal health coverage such as South
Africa. In other parts of Africa, nationalized health
insurance remains out of reach. Most Africans pay out-
of-pocket for their health expenses, which are
supplemented somewhat by a few free services from
government and donor organizations which mainly focus
on infectious disease treatment with HIV/AIDS control
efforts taking a lion’s share of this funding [55]. This
calls for more innovative ways of financing care for
chronic non-communicable disease on the continent.
The studies considered in this review revealed gener-
ally dismal rates of control of hypertension. The lowest
rates of control were seen in Tanzania in studies span-
ning 10 years. Even in countries that had impressive
rates of treatment, control of blood pressure to target
remained elusive in many. This means that treatment of
hypertension does not guarantee control, the ultimate
predictor of outcomes. Several of the included studies
from different countries blamed various factors for poor
blood pressure control. These can generally be categorised
as such as the health-system deficiencies, patients’ non-
adherence and the physicians’ inertia in treating hyperten-
sion and they seem to be in play on the African continent.
For example, the lack of anti-hypertensive medication at
health facilities and the long distance to the health facil-
ities reported in some studies are characteristic health sys-
tem shortcomings hindering the achievement of control
[28,44]. On the other hand the lack of time and reported
competing priorities are classical patient and physician
factors adding to the problem [45].
Blood pressure in women was generally better con-
trolled than in men in Africa. In two studies in Tanzania
and Nigeria, the men were more aware of their status
and were more likely to receive treatment. Still, the
women achieved better control rates. The issue of gen-
der differences in hypertension has been a subject of in-
tense research. It is now recognised that young men are
more likely to develop hypertension than women, a dy-
namic that has been blamed on androgen mediated ab-
normalities in pressure natrieusis [56]. However, large
meta-analyses of hypertension treatment trials have
failed to document gender differences in response to an-
tihypertensive medication meaning that the poor control
of hypertension documented in men is probably due to
socio-economic and cultural factors [57]. In other parts
of the world, control of blood pressure seems to be
poorer in women. This is possibly because these studies
have largely considered elderly men and women [58,59].
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better control. In various studies in the African setting,
the women seem to have better health seeking behaviour
for chronic disease than men [60,61]. It is also possible
that women benefit from screening due to more contact
with healthcare facilities during the reproductive years
[62]. The men, on the other hand, are less enthusiastic in
seeking care. Indeed in one included study from Angola,
men reportedly did not pick up their antihypertensive
medication because they lacked time [28]. The finding
supports the establishment of gender-specific programs
for the treatment and control of blood pressure.
There were certain limitations in this review. The use
of one database may have limited the number of articles
obtained for the review. However, by searching the
PubMed database we limited our search to peer-
reviewed sources which offered a firm guarantee that the
publications used were appropriate for review [63].
As previously mentioned, these studies were heteroge-
neous in nature which made further analysis difficult. In
addition, the cross-sectional nature of the considered
studies complicated efforts to discuss the trends in aware-
ness, treatment and control. In Tanzania, frequent studies
have been done in the capital Dar es Salaam over time and
so we commented on trends [24,26]. There is need to
carry out surveillance or follow-up cohorts in order to
study the trends of hypertension status. A further limita-
tion with most of the reviewed studies was the failure to
study the factors that contributed to the current hyperten-
sion status on the continent which calls for systematic
study of these factors to inform interventions and policy.
Other draw-backs included non-random selection of par-
ticipants in some of the studies [30,44] the under-
representation of the central African region.
Conclusion
This systematic review confirms the low levels of treat-
ment and awareness. Most notably, the level of control is
abysmal in most countries in Africa, which implies that
diagnosis and treatment does not guarantee reaching tar-
gets of control. This situation explains the poor outcomes
of patients affected with hypertension on the continent.
While health system factors play a key part in perpetuating
this state of affairs, patient factors are also important de-
terminants of control. These factors may differ in gender
and on different parts of the continent necessitating tai-
lored research and policy formulation to improve the out-
comes of patients affected by hypertension. In addition,
there is need to design tailored chronic care models on a
continent whose focus has thus far been the control of
acute infectious disease.Competing interests
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